NIMH | Technology Transfer

Methods for Expression and Purification of Immunotoxins

Read more about Methods for Expression and Purification of Immunotoxins

The Netherlands
04779747.7
Filed on 2004-08-02

Methods for Expression and Purification of Immunotoxins

Read more about Methods for Expression and Purification of Immunotoxins

Austria
04779747.7
Filed on 2004-08-02

Methods for Expression and Purification of Immunotoxins

Read more about Methods for Expression and Purification of Immunotoxins

Germany
04779747.7
Filed on 2004-08-02

Methods for Expression and Purification of Immunotoxins

Read more about Methods for Expression and Purification of Immunotoxins

France
04779747.7
Filed on 2004-08-02

Methods for Expression and Purification of Immunotoxins

Read more about Methods for Expression and Purification of Immunotoxins

United Kingdom
04779747.7
Filed on 2004-08-02

Scopolamine For The Treatment Of Depression And Anxiety

Read more about Scopolamine For The Treatment Of Depression And Anxiety

United Kingdom
06760136.9
Filed on 2006-05-18

Scopolamine For The Treatment Of Depression And Anxiety

Read more about Scopolamine For The Treatment Of Depression And Anxiety

France
06760136.9
Filed on 2006-05-18

Scopolamine For The Treatment Of Depression And Anxiety

Read more about Scopolamine For The Treatment Of Depression And Anxiety

Germany
06760136.9
Filed on 2006-05-18

SCHIZOPHRENIA-RELATED ISOFORM OF KCNH2 AND DEVELOPMENT OF ANTIPSYCHOTIC DRUGS

Read more about SCHIZOPHRENIA-RELATED ISOFORM OF KCNH2 AND DEVELOPMENT OF ANTIPSYCHOTIC DRUGS

US Patent 8,871,443
Filed on 2012-01-24

Phosphatidylinositol-3-Kinase P110 Delta-Targeted Drugs In The Treatments Of CNS Disorders

Read more about Phosphatidylinositol-3-Kinase P110 Delta-Targeted Drugs In The Treatments Of CNS Disorders

US Application 13/132,425
Filed on 2011-08-17

Subscribe to NIMH